Acute necrotizing encephalopathy and myocarditis in a young patient with COVID-19

  • Elkady A
  • Rabinstein A
N/ACitations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

A 33-year-old woman, previously healthy was admitted with generalized status epilepticus. Four days before, she had developed generalized fatigue, fever, headache, and nasal congestion. On hospital arrival, she was comatose (Glasgow coma scale 5 [E1/V1/M3]), febrile (38.6°C), tachycardic (145/min) with a blood pressure of 100/60 mm Hg, and tachypneic (35/min) with hypoxemia (pulse oximetry 80%). She was emergently intubated and started on mechanical ventilation and received IV midazolam and valproic acid for seizure control. Chest x-ray showed mild edema. The initial blood test results showed elevated myocardial enzymes; high-sensitivity troponin-I, 2,210 pg/mL; probrain natriuretic peptide, 992 pg/ mL; creatine phosphokinase, 1858 mcg/L; and creatine kinase-MB, 22.5 ng/mL. Blood count revealed a white blood cell count of 14550/μL with absolute lymphopenia of 0.92/μL. C-reactive protein and erythrocyte sedimentation rate levels were high, whereas procalci-tonin and lactic acid were normal. ECG showed sinus tachycardia and diffuse ST segment elevation. Bedside echocardiography showed diffuse myocardial dyskinesia with low left ventricular ejection fraction (29%) and small pericardial effusion. Head CT showed diffuse brain edema. On day 2, brain MRI showed bilateral hemorrhagic thalamic (figure, A-C) and cerebellar lesions (figure, E-G). Noninvasive and invasive cerebral angiographies excluded venous or arterial occlusions and showed no signs of vasculitis. Lumbar puncture had an opening pressure of 22 cmH 2 O, and CSF showed a white cell count of 26 cells/μL (90% lympho-cytes), protein of 541 mg/dL, no oligoclonal bands, and normal glucose; PCR tests results for herpes simplex types 1 and 2, varicella-zoster, cytomegalovirus, Epstein-Barr virus, West Nile virus, Coxsackie viruses, echovirus, and dengue were negative. Testing for the presence of SARS-CoV2 in the CSF was unable to be performed. Follow-up chest x-ray showed worsening bilateral alveolar and interstitial lung edema. Serum interleukin-6 (IL-6) was 378 pg/mL, whereas IL-6 in the CSF was not performed. High-dose IV methylprednisolone (1,000 mg/d) was started for presumptive diagnosis of acute necrotizing encephali-tis (ANE). On day 3, a nasopharyngeal swab specimen was tested for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Follow-up brain MRI with gadolinium showed rim enhancement of the bilateral thalamic and cerebellar lesions (figure, D and H); it also disclosed signs of acute pansinusitis (figure, H). Cardiac MRI showed diffuse myocardial signal hyperintensity in both ventricles and associated pericarditis. Blood tests for autoimmune diseases were negative; moreover, blood, urine, and sputum cultures revealed no organism growth. On day 4, the patient remained comatose and hypoxemic. Blood tests revealed new thrombocytopenia and elevated liver enzymes. The patient then had sudden neurologic deterioration with anisocoria and extensor posturing. Emergent head CT demonstrated diffuse brain swelling with right thalamic and right cerebellar hemorrhages.

Cite

CITATION STYLE

APA

Elkady, A., & Rabinstein, A. A. (2020). Acute necrotizing encephalopathy and myocarditis in a young patient with COVID-19. Neurology Neuroimmunology & Neuroinflammation, 7(5). https://doi.org/10.1212/nxi.0000000000000801

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free